Chapman AG - Search Results

1

GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice.

de Sarro G, Chimirri A, De Sarro A, Gitto R, Grasso S, Giusti P, Chapman AG. de Sarro G, et al. Among authors: chapman ag. Eur J Pharmacol. 1995 Dec 29;294(2-3):411-22. doi: 10.1016/0014-2999(95)00561-7. Eur J Pharmacol. 1995. PMID: 8750701

2

1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.

Chimirri A, De Sarro G, De Sarro A, Gitto R, Grasso S, Quartarone S, Zappalà M, Giusti P, Libri V, Constanti A, Chapman AG. Chimirri A, et al. Among authors: chapman ag. J Med Chem. 1997 Apr 11;40(8):1258-69. doi: 10.1021/jm960506l. J Med Chem. 1997. PMID: 9111300

3

Glutamate metabotropic receptors as targets for drug therapy in epilepsy.

Moldrich RX, Chapman AG, De Sarro G, Meldrum BS. Moldrich RX, et al. Among authors: chapman ag. Eur J Pharmacol. 2003 Aug 22;476(1-2):3-16. doi: 10.1016/s0014-2999(03)02149-6. Eur J Pharmacol. 2003. PMID: 12969743 Review.

4

Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice.

Chapman AG, al-Zubaidy Z, Meldrum BS. Chapman AG, et al. Eur J Pharmacol. 1993 Feb 9;231(2):301-3. doi: 10.1016/0014-2999(93)90465-t. Eur J Pharmacol. 1993. PMID: 8453982

5

Kainic acid derivatives with anticonvulsant activity.

Collins JF, Dixon AJ, Badman G, De Sarro G, Chapman AG, Hart GP, Meldrum BS. Collins JF, et al. Among authors: chapman ag. Neurosci Lett. 1984 Oct 26;51(3):371-6. doi: 10.1016/0304-3940(84)90405-1. Neurosci Lett. 1984. PMID: 6521964

6

Bidirectional effects of beta-carbolines in reflex epilepsy.

Chapman AG, De Sarro GB, Premachandra M, Meldrum BS. Chapman AG, et al. Brain Res Bull. 1987 Sep;19(3):337-46. doi: 10.1016/0361-9230(87)90102-x. Brain Res Bull. 1987. PMID: 3119161

7

Potent oral anticonvulsant action of CPP and CPPene in DBA/2 mice.

Chapman AG, Graham J, Meldrum BS. Chapman AG, et al. Eur J Pharmacol. 1990 Mar 13;178(1):97-9. doi: 10.1016/0014-2999(90)94798-3. Eur J Pharmacol. 1990. PMID: 2332032

8

Anticonvulsant action and biochemical effects in DBA/2 mice of CPP (3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonate), a novel N-methyl-D-aspartate antagonist.

Chapman AG, Meldrum BS, Nanji N, Watkins JC. Chapman AG, et al. Eur J Pharmacol. 1987 Jul 2;139(1):91-6. doi: 10.1016/0014-2999(87)90501-2. Eur J Pharmacol. 1987. PMID: 3308490

9

Anticonvulsant actions of LY 367385 ((+)-2-methyl-4-carboxyphenylglycine) and AIDA ((RS)-1-aminoindan-1,5-dicarboxylic acid).

Chapman AG, Yip PK, Yap JS, Quinn LP, Tang E, Harris JR, Meldrum BS. Chapman AG, et al. Eur J Pharmacol. 1999 Feb 26;368(1):17-24. doi: 10.1016/s0014-2999(99)00014-x. Eur J Pharmacol. 1999. PMID: 10096765

10

Anticonvulsant activity of a metabotropic glutamate receptor 8 preferential agonist, (R,S)-4-phosphonophenylglycine.

Chapman AG, Nanan K, Yip P, Meldrum BS. Chapman AG, et al. Eur J Pharmacol. 1999 Oct 21;383(1):23-7. doi: 10.1016/s0014-2999(99)00615-9. Eur J Pharmacol. 1999. PMID: 10556677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters